About N-Power Medicine
N-Power Medicine is a Healthcare company based in Redwood City (United States) founded in 2021 by Christer Svedman and Mark Lee. Clinical trial services are provided to support medical research initiatives. N-Power Medicine has raised $32 million across 2 funding rounds from investors including Merck Global Health Innovation Fund, LabCorp and Innovatus Capital Partners. N-Power Medicine has completed 1 acquisition, including Syapse. Its chief executive, as recorded, is Mark Lee. N-Power Medicine offers products and services including N-Power Platform, Clinical Trial Suite, Data Generation Suite, and Kaleidoâ„¢ Registry. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is N-Power Medicine, Inc. Its competitors include Clario, Lightship and SFJ Pharmaceuticals; 2 of its 3 listed competitors have raised funding.
Company details
N-Power Medicine was founded in 2021 and is based in Redwood City, United States. Clinical trial services are offered within the healthcare sector, focusing on trial management, patient recruitment, and data analysis for pharmaceutical clients. Operations are conducted to ensure regulatory compliance and efficiency in drug development processes. The company is led by co-founders Christer Svedman and Mark Lee, the latter serving as CEO.
- Headquarters Redwood City, United States
- Founders Christer Svedman, Mark Lee
- SectorsHealthcare
- Website npowermedicine.com
- Social LinkedIn
- Legal Name N-Power Medicine, Inc.
- Total Equity Funding$32M (USD)
in 2 rounds
- Latest Funding Round$32M (USD), Series B
Sep 2026
- InvestorsMerck Global Health Innovation Fund
& 2 more
- Investments & Acquisitions
Products & Services of N-Power Medicine
N-Power Medicine offers a comprehensive portfolio of products and services, including N-Power Platform, Clinical Trial Suite, Data Generation Suite, and Kaleido™ Registry.
Platform for accelerating drug development through standardized data collection.
Tools for managing oncology trials and improving research operations.
Suite for generating and analyzing routine care data in clinical research.
Registry ensuring real-time, standardized data for oncology studies.
Funding Insights of N-Power Medicine
N-Power Medicine has successfully raised a total of $32M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $32 million completed in September 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $32M
- Total Rounds 2
- Last Round Series B — $32M
- Investors Count 3
All 2 funding rounds of N-Power Medicine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2026 | $32M | Series B | – | – | |
| Jul 2024 | Series B | – | Merck Global Health Innovation Fund | – |
3 investors in total: 3 institutional.
Investors in N-Power Medicine
N-Power Medicine has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck Global Health Innovation Fund, LabCorp and Innovatus Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital is focused on the life science sector. | merckghifund.com | Kenilworth, United States | ||
| innovatuscp.com | ||||
| labcorp.com |
Investor details for N-Power Medicine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of N-Power Medicine
26 people are tracked at N-Power Medicine (10 in leadership, 16 in team).
| Name | Role | Group |
|---|---|---|
Christer Svedman | Co-Founder | Leadership |
Mark Lee | Co-Founder & CEO | Leadership |
Anna (Ania) Schwarzbach | Head Of Network Strategy | Leadership |
Maria Ferrari | Chief Of Staff And Head Of Program Management | Leadership |
Sam Gebai, SPHR | Human Resources Director | Leadership |
Ruchika Kumar | General Counsel & Head Of People | Leadership |
Thomas Bengtsson | Head, Data Science | Leadership |
Whitney Gilbert Hoover | Network Partner Liaison | Leadership |
Christer Svedman MD PhD | Co-founder, Head Of Clinical Science | Leadership |
Jonathan Daniels | Head Of Business Development And Partnering | Leadership |
Elizabeth Lamont | Principal Clinical Scientist | Team |
Lyndsey Goyette, BS, CTR | Senior Manager, Clinical Platform & Data Quality | Team |
Amelia Deitsch | Data Quality Analyst III | Team |
Adam Jonas | Principle - Data Acquisition | Team |
Gregory Chin | Senior QA Engineer | Team |
Hina Mohammed | Senior Data Scientist | Team |
Connor Sweetnam | Principal Data Scientist | Team |
Erick Chavez | Digital Health Specialist II | Team |
Leslie Hess | Senior Recruiter | Team |
Shae Owens | Data | Team |
6 more people are available in the full profile.
Complete people profiles for N-Power Medicine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by N-Power Medicine
N-Power Medicine has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Syapse.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of precision medicine for the treatment of cancer | syapse.com | San Francisco, United States | 2008 | Jan 2025 | •••• |
Complete acquisition details for N-Power Medicine
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of N-Power Medicine
4 dated milestones of N-Power Medicine across 5 years, from founding to its latest funding, stage changes and deals.
- Founded N-Power Medicine is founded.
- Funding First funding round.
- Acquisition Acquires Syapse.
- Funding Latest funding round, Series B, of $32.0M.
Competitors of N-Power Medicine
N-Power Medicine has 3 listed competitors in our database, 2 of them funded. They include Clario, Lightship and SFJ Pharmaceuticals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| clario.com | 1972 | Philadelphia, United States | 11 | CRO focused on providing clinical trial supply services for biopharma sector | ||
| lightship.com | 1995 | El Segundo, United States | $205.55M | 74 | Direct-to-patient clinical trial solutions are provided by Lightship. | |
| sfj-pharma.com | 2008 | Pleasanton, United States | $69.5M | 12 | Specialty pharmaceutical company based on partnering model |
Detailed competitors of N-Power Medicine
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of N-Power Medicine
The website of N-Power Medicine (npowermedicine.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 7.4% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as N-Power Medicine (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about N-Power Medicine
Complete news archive for N-Power Medicine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about N-Power Medicine
N-Power Medicine was founded in 2021 and raised its 1st funding round 3 years after it was founded.
N-Power Medicine is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Mark Lee is the CEO of N-Power Medicine, as recorded in our data. They have also founded this company.
N-Power Medicine is a funded company, having raised a total of $32M across 2 funding rounds to date.
N-Power Medicine was founded in 2021 and is based in Redwood City, United States. Clinical trial services are offered within the healthcare sector, focusing on trial management, patient recruitment, and data analysis for pharmaceutical clients. Operations are conducted to ensure regulatory compliance and efficiency in drug development processes. The company is led by co-founders Christer Svedman and Mark Lee, the latter serving as CEO.
N-Power Medicine's top competitors include Lightship, SFJ Pharmaceuticals and Clario.
N-Power Medicine offers N-Power Platform, Clinical Trial Suite, Data Generation Suite, and Kaleidoâ„¢ Registry.
N-Power Medicine has made 1 acquisition, including Syapse.
N-Power Medicine has 3 investors. Key investors include Merck Global Health Innovation Fund, LabCorp, and Innovatus Capital Partners.
N-Power Medicine operates through N-Power Medicine, Inc..